RegenMed is partnering with Summus Medical Laser to establish a comprehensive real-world evidence program.  Summus, a U.S. corporation, has distributed thousands of its Class IV laser systems to over fifty countries.  Those systems have been used to deliver millions of treatments for a variety of indications.   Summus lasers are used by physicians, chiropractors, veterinarians, and dental professionals.

The initial Circle designed by Summus, in conjunction with its clinical thought-leaders, will collect and analyze real-world evidence on peripheral neuropathy from dozens of practitioners in the U.S.  Each practitioner will be able to customize clinical surveys to match the realities of his/her practice, without compromising the overall clinical and statistical significance of the aggregated datasets.  For example, both bi-lateral and unilateral presentations of peripheral neuropathy will be accommodated.  

A key part of the Summus Real-World Evidence Program will be regular reports to its clinical customers regarding trends, observations, best practices, and other correlations.  These reports will be supplemented by livestreamed sessions among Circle members to review learnings, comments, and questions.  In addition, RegenMed will regularly provide to Summus separate reports on patient compliance, clinical customer metrics, correlations suggesting new indications, potential product improvements, and other data-driven observations.  

In parallel with the growth of the peripheral neuropathy Circle, the Summus Real-World Evidence Program will expand to offer additional Circles across a variety of indications and international regions.

For more information, please contact us.